Adaptive Biotechnologies Corporation Stock
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 27.67 USD | +3.71% |
|
+13.31% | +70.38% |
| 08-20 | Adaptive Biotechnologies Insider Sold Shares Worth $3,135,850, According to a Recent SEC Filing | MT |
| 07-30 | Adaptive Biotechnologies Q2 Loss Widens, Revenue Rise | MT |
| Market Cap | 4.42B 3.83B 3.62B 3.28B 6.15B 424B 6.19B 43.18B 16.69B 215B 16.59B 16.22B 685B | P/E 2026 * |
-50.8x | P/E 2027 * | -157x |
|---|---|---|---|---|---|
| Enterprise Value | 4.36B 3.78B 3.57B 3.24B 6.07B 418B 6.11B 42.6B 16.46B 212B 16.37B 16B 676B | EV / Sales 2026 * |
14.9x | EV / Sales 2027 * | 12x |
| Free-Float |
97.94% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
|
Tradegate
| 1HM | Real-time | |
|
Deutsche Boerse AG
| 1HM | Delayed | |
|
Börse Stuttgart
| 1HM | Delayed | |
|
Boerse Muenchen
| 1HM | Real-time |
Last Transcript: Adaptive Biotechnologies Corporation
| 1 day | +3.71% | ||
| 1 week | +13.31% | ||
| Current month | +11.04% | ||
| 1 month | +11.84% | ||
| 3 months | +60.69% | ||
| 6 months | +107.73% | ||
| Current year | +70.38% |
| 1 week | 23.93 |  | 28.72 |
| 1 month | 23.53 | | 28.72 |
| Current year | 12 | | 28.72 |
| 1 year | 12 | | 28.72 |
| 3 years | 2.28 | | 28.72 |
| 5 years | 2.28 | | 39.62 |
| 10 years | 2.28 | | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chad Robins
CEO | Chief Executive Officer | 51 | 2009-09-07 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 2024-04-07 |
Julie Rubinstein
PSD | President | 54 | 2018-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 2013-01-31 |
Peter Neupert
BRD | Director/Board Member | 70 | 2013-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 | Don | Director | -12,539 | 0.0079% | ||
| 8/26/26 | Sell | Director | -9,615 | 0.0060% | ||
| 8/18/26 | Exercice | Director | 60,664 | 0.0379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.71% | +13.31% | +114.33% | +356.60% | 4.42B | |
| +5.45% | +17.08% | +329.13% | +87.29% | 4.47B | |
| -4.09% | -12.22% | +19.27% | +53.69% | 3.1B | |
| +1.73% | +7.04% | +277.64% | +576.14% | 2.77B | |
| +1.49% | +0.19% | -29.65% | -30.63% | 2.11B | |
| +0.61% | -6.48% | +39.62% | - | 1.58B | |
| +0.62% | +6.92% | +25.05% | +40.78% | 1.08B | |
| -0.58% | -1.58% | +136.68% | -34.61% | 1.02B | |
| -3.56% | -2.57% | -8.24% | +70.32% | 595M | |
| +0.75% | -3.06% | -34.49% | -22.16% | 512M | |
| Average | +0.61% | +2.41% | +86.93% | +121.94% | 2.17B | |
| Weighted average by Cap. | +1.63% | +5.50% | +136.19% | +184.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 293M 254M 240M 218M 409M 28.13B 411M 2.87B 1.11B 14.27B 1.1B 1.08B 45.48B | 359M 311M 294M 267M 500M 34.39B 503M 3.51B 1.35B 17.45B 1.35B 1.32B 55.61B |
| Net income | -85.78M -74.34M -70.26M -63.79M -120M -8.23B -120M -839M -324M -4.17B -322M -315M -13.3B | -27.55M -23.88M -22.57M -20.49M -38.4M -2.64B -38.63M -269M -104M -1.34B -103M -101M -4.27B |
| Net Debt | -58.99M -51.12M -48.32M -43.87M -82.22M -5.66B -82.71M -577M -223M -2.87B -222M -217M -9.15B | -104M -89.98M -85.05M -77.21M -145M -9.96B -146M -1.02B -392M -5.05B -390M -381M -16.1B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-16 | US$27.67 | +3.71% | 5,026,486 |
| 26-09-15 | US$26.68 | +7.67% | 4,124,280 |
| 26-09-14 | US$24.78 | +2.40% | 1,730,383 |
| 26-09-11 | US$24.20 | -0.12% | 1,238,268 |
| 26-09-10 | US$24.23 | -0.78% | 1,071,432 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions
